Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Elfenac Roll On is a topical combination formulation developed by Captab Biotec for the relief of musculoskeletal and orthopedic pain. It contains diclofenac diethylamine (a nonsteroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes), methyl salicylate (a topical analgesic and counterirritant), linseed oil (which has anti-inflammatory properties), menthol (a cooling agent and counterirritant), and capsaicin (a transient receptor potential vanilloid 1 agonist that desensitizes nociceptors). This combination is designed to provide rapid and localized relief from joint pain, muscle strains, sprains, and other orthopedic conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Elfenac Roll On.